Detalhe da pesquisa
1.
Phase I trial of antigen-targeted autologous dendritic cell-based vaccine with in vivo activation of inducible CD40 for advanced prostate cancer.
Cancer Immunol Immunother
; 66(10): 1345-1357, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28608115
2.
Cord-blood engraftment with ex vivo mesenchymal-cell coculture.
N Engl J Med
; 367(24): 2305-15, 2012 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-23234514
3.
Interlaboratory assessment of a novel colony-forming unit assay: a multicenter study by the cellular team of Biomedical Excellence for Safer Transfusion (BEST) collaborative.
Transfusion
; 51(9): 2001-5, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21569039
4.
Large-scale preparation of human anti-third-party veto cytotoxic T lymphocytes depleted of graft-versus-host reactivity: a new source for graft facilitating cells in bone marrow transplantation.
Hum Immunol
; 66(6): 644-52, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15993710
5.
Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans.
PLoS One
; 7(4): e34833, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22558101
6.
Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients.
Clin Cancer Res
; 18(24): 6758-70, 2012 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23032743
7.
Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy.
Clin Cancer Res
; 17(14): 4882-91, 2011 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21632855
8.
Ex vivo graft purging and expansion of autologous blood progenitor cell products from patients with multiple myeloma.
Cancer Res
; 71(14): 5040-9, 2011 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21646477
9.
Hematopoietic progenitor cell collection in patients with chronic myelogenous leukemia in complete cytogenetic remission after imatinib mesylate therapy.
Leuk Lymphoma
; 51(8): 1478-84, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20658954
10.
Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 exvivo expansion.
J Immunother
; 33(7): 684-96, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20664358
11.
Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer.
Int J Hematol
; 90(5): 627-634, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19998065
12.
Double loading of dendritic cell MHC class I and MHC class II with an AML antigen repertoire enhances correlates of T-cell immunity in vitro via amplification of T-cell help.
Vaccine
; 24(16): 3203-16, 2006 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-16480795
13.
Bone marrow purging studies in acute myelogenous leukemia using the recombinant anti-CD33 immunotoxin HuM195/rGel.
Biol Blood Marrow Transplant
; 9(6): 364-72, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12813444